Meeting
2018 Gastrointestinal Cancers Symposium
Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant colon cancer: Experience in Ramon y Cajal University Hospital.
Authors
Olga Martinez Saez
Ramon y Cajal, Madrid, Spain
Olga Martinez Saez , Maria Villamayor Delgado , Cristina Saavedra Serrano , Elena Corral de la Fuente , Juan José Serrano Domingo , Roberto Martín Huertas , Pablo Reguera Puertas , FEDERICO LONGO , Vanessa Pachon , Mercedes Rodríguez Garrote , Carmen Guillen , Alfredo Carrato , Reyes Ferreiro Monteagudo , Arantzazu Martínez Barquín García
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 815)
DOI
10.1200/JCO.2018.36.4_suppl.815
Abstract #
815
Poster Bd #
M14
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
First Author: Suganija Lakkunarajah
Poster
2018 Gastrointestinal Cancers Symposium
Benefit of adjuvant treatment in stages II and III colon cancer: Experience at the Ramón y Cajal University Hospital.
First Author: Olga Martinez Saez
Poster
2013 ASCO Annual Meeting
Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.
First Author: Jean-François Flejou
Poster
2013 Gastrointestinal Cancers Symposium
Effectiveness of capecitabine plus oxaliplatin for advanced colon cancer: A public hospital experience.
First Author: Carrie Luu